Silvia Bozzarelli

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Current oncology (Toronto, Ont.)

Cancers

Journal of personalized medicine

Expert opinion on investigational drugs

Istituto Clinico Humanitas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Clinico Humanitas Mar 20 2008

Italy

phisician :: oncology

Publications

Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Gennaro Nappo, Greta Donisi, Giovanni Capretti, Cristina Ridolfi, Michele Pagnanelli, Martina Nebbia, Silvia Bozzarelli, Tommasangelo Petitti, Francesca Gavazzi, Alessandro Zerbi
Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma. Current oncology (Toronto, Ont.) 30 (4) (2023)
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Gennaro Nappo, Greta Donisi, Giovanni Capretti, Cristina Ridolfi, Michele Pagnanelli, Martina Nebbia, Silvia Bozzarelli, Tommasangelo Petitti, Francesca Gavazzi, Alessandro Zerbi
Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma. Current oncology (Toronto, Ont.) 30 (4) (2023)
Tiziana Comito, Maria Massaro, Maria Ausilia Teriaca, Ciro Franzese, Davide Franceschini, Pierina Navarria, Elena Clerici, Luciana Di Cristina, Anna Bertolini, Stefano Tomatis, Giacomo Reggiori, Andrea Bresolin, Silvia Bozzarelli, Lorenza Rimassa, Cristiana Bonifacio, Silvia Carrara, Armando Santoro, Alessandro Zerbi, Marta Scorsetti
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study). Current oncology (Toronto, Ont.) 30 (7) (2023)
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Gennaro Nappo, Greta Donisi, Giovanni Capretti, Cristina Ridolfi, Michele Pagnanelli, Martina Nebbia, Silvia Bozzarelli, Tommasangelo Petitti, Francesca Gavazzi, Alessandro Zerbi
Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma. Current oncology (Toronto, Ont.) 30 (4) (2023)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Silvia Bozzarelli, Nicola Personeni, Lorenza Rimassa
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Manish A Shah, Anghel Adrian Udrea, Igor Bondarenko, Was Mansoor, Raquel Guardeño Sánchez, Tomasz Sarosiek, Silvia Bozzarelli, Michael Schenker, Carlos Gomez-Martin, Carys Morgan, Mustafa Özgüroğlu, Joanna Pikiel, Haralabos P Kalofonos, Elzbieta Wojcik, Tomas Buchler, Daniel Swinson, Irfan Cicin, Mano Joseph, Ihor Vynnychenko, Alexander Valerievich Luft, Peter C Enzinger, Tomas Salek, Christos Papandreou, Christophe Tournigand, Evaristo Maiello, Ran Wei, David Ferry, Ling Gao, Joana M Oliveira, Jaffer A Ajani
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies. Cancers 14 (5) (2022)
Nicola Personeni, Laura Giordano, Angelica Michelini, Antonio D'Alessio, Antonella Cammarota, Silvia Bozzarelli, Tiziana Pressiani, Maria Giuseppina Prete, Maria Teresa Sandri, Sabine Stioui, Luca Germagnoli, Armando Santoro, Lorenza Rimassa, Rossana Mineri
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. Journal of personalized medicine 12 (2) (2022)
Nicola Personeni, Tiziana Pressiani, Antonio D'Alessio, Maria Giuseppina Prete, Silvia Bozzarelli, Luigi Terracciano, Arianna Dal Buono, Antonio Capogreco, Alessio Aghemo, Ana Lleo, Romano Fabio Lutman, Massimo Roncalli, Laura Giordano, Armando Santoro, Luca Di Tommaso, Lorenza Rimassa
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers 13 (22) (2021)
Manlio Monti, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, Silvia Bozzarelli, Annibale Donini, Luigina Graziosi, Verena De Angelis, Giovanni De Manzoni, Maria Bencivenga, Valentina Mengardo, Emilio Parma, Carlo Milandri, Gianni Mura, Alessandra Signorini, Gianluca Baiocchi, Sarah Molfino, Giovanni Sgroi, Francesca Steccanella, Stefano Rausei, Ilaria Proserpio, Jacopo Viganò, Silvia Brugnatelli, Andrea Rinnovati, Stefano Santi, Giorgio Ercolani, Flavia Foca, Linda Valmorri, Dino Amadori, Giovanni Luca Frassineti
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers 12 (10) (2020)

Silvia Bozzarelli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia Bozzarelli